TY - JOUR
T1 - Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle
AU - Kuperman, Yael
AU - Issler, Orna
AU - Vaughan, Joan
AU - Bilezikjian, Louise
AU - Vale, Wylie
AU - Chen, Alon
N1 - Clayton Medical Research Foundation, Inc.; Roberto and Renata Ruhman, Brazil; Mark Besen and the Pratt Foundation, Australia; Israel Science Foundation; Legacy Heritage Biomedical Science Partnership; Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer; Gerhard and Hannah Bacharach (Fort Lee, NJ); National Institute of Diabetes and Digestive and Kidney Diseases [5P01DK026741-30]This research was supported in part by the Clayton Medical Research Foundation, Inc. A.C. was supported by the following: Roberto and Renata Ruhman, Brazil; Mark Besen and the Pratt Foundation, Australia; the Israel Science Foundation; the Legacy Heritage Biomedical Science Partnership D-Cure Fellowship; Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer's Research Fund; Gerhard and Hannah Bacharach (Fort Lee, NJ) and is incumbent of the Philip Harris and Gerald Ronson Career Development Chair. W.V. was supported by Award No. 5P01DK026741-30 from the National Institute of Diabetes and Digestive and Kidney Diseases and is a Clayton Medical Research Foundation, Inc. Senior Investigator and the Helen McLoraine Professor of Molecular Neurobiology.
PY - 2011/1
Y1 - 2011/1
N2 - Corticotropin-releasing factor receptor type 2 (CRFR2) is highly expressed in skeletal muscle (SM) tissue where it is suggested to inhibit interactions between insulin signaling pathway components affecting whole-body glucose homeostasis. However, little is known about factors regulating SM CRFR2 expression. Here, we demonstrate the exclusive expression of CRFR2, and not CRFR1, in mature SM tissue using RT-PCR and ribonuclease protection assays and report a differential expression of CRF receptors during C2C12 myogenic differentiation. Whereas C2C12 myoblasts exclusively express CRFR1, the C2C12 myotubes solely express CRFR2. Using cAMP luciferase assays and calcium mobilization measurements, we further demonstrate the functionality of these differentially expressed receptors. Using luciferase reporter assays we show a differential activation of CRFR promoters during myogenic differentiation. Transfections with different fragments of the 5'-flanking region of the mCRFR2β gene fused to a luciferase reporter gene show a promoterdependent expression of the reporter gene and reveal the importance of the myocyte enhancer factor 2 consensus sequence located at the 3'-proximal region of CRFR2β promoter. Furthermore, we demonstrate that CRFR2 gene transcription in the mature mouse is stimulated by both high-fat diet and chronic variable stress conditions. Performing a whole-genome expression microarray analysis of SM tissues obtained from CRFR2-null mice or wild-type littermates revealed a robust reduction in retinol-binding protein 4 expression levels, an adipokine whose serum levels are elevated in insulin-resistant states. In correlation with the SM CRFR2β levels, the SM retinolbinding protein 4 levels were also elevated in mice subjected to high-fat diet and chronic variable stress conditions. The current findings further position the SM CRFR2 pathways as a relevant physiological system that may affect the known reciprocal relationship between psychological and physiological challenges and the metabolic syndrome. (Molecular Endocrinology 25: 157-169, 2011).
AB - Corticotropin-releasing factor receptor type 2 (CRFR2) is highly expressed in skeletal muscle (SM) tissue where it is suggested to inhibit interactions between insulin signaling pathway components affecting whole-body glucose homeostasis. However, little is known about factors regulating SM CRFR2 expression. Here, we demonstrate the exclusive expression of CRFR2, and not CRFR1, in mature SM tissue using RT-PCR and ribonuclease protection assays and report a differential expression of CRF receptors during C2C12 myogenic differentiation. Whereas C2C12 myoblasts exclusively express CRFR1, the C2C12 myotubes solely express CRFR2. Using cAMP luciferase assays and calcium mobilization measurements, we further demonstrate the functionality of these differentially expressed receptors. Using luciferase reporter assays we show a differential activation of CRFR promoters during myogenic differentiation. Transfections with different fragments of the 5'-flanking region of the mCRFR2β gene fused to a luciferase reporter gene show a promoterdependent expression of the reporter gene and reveal the importance of the myocyte enhancer factor 2 consensus sequence located at the 3'-proximal region of CRFR2β promoter. Furthermore, we demonstrate that CRFR2 gene transcription in the mature mouse is stimulated by both high-fat diet and chronic variable stress conditions. Performing a whole-genome expression microarray analysis of SM tissues obtained from CRFR2-null mice or wild-type littermates revealed a robust reduction in retinol-binding protein 4 expression levels, an adipokine whose serum levels are elevated in insulin-resistant states. In correlation with the SM CRFR2β levels, the SM retinolbinding protein 4 levels were also elevated in mice subjected to high-fat diet and chronic variable stress conditions. The current findings further position the SM CRFR2 pathways as a relevant physiological system that may affect the known reciprocal relationship between psychological and physiological challenges and the metabolic syndrome. (Molecular Endocrinology 25: 157-169, 2011).
UR - http://www.scopus.com/inward/record.url?scp=78650868297&partnerID=8YFLogxK
U2 - 10.1210/me.2010-0308
DO - 10.1210/me.2010-0308
M3 - مقالة
SN - 0888-8809
VL - 25
SP - 157
EP - 169
JO - Molecular Endocrinology
JF - Molecular Endocrinology
IS - 1
ER -